With an array of finished products and potential health benefits, curcumin boasts a global market that’s expected to grow by $32.11 million between 2020 and 2024.

Curcumin’s therapeutic benefits related to inflammation and joint health are becoming better known, while new formulations are improving the bioactive compound’s performance.

Although an omega-3 dietary requirement for adult dogs has not been formalized, research in humans and canines indicates it could provide numerous potential benefits.

Curcumin’s popularity continues to grow with consumers, as the research into its health benefits and disease mediation also keeps on expanding.

Nutrition, including supplementation, can have a beneficial impact on the various mechanisms and immune cells involved in acute or chronic inflammation.

Joint health products are tapping into clinically supported ingredients, proprietary blends, delivery technologies, consumer appeal and more.